Glycopyrrolate Tablets, USP, 1 mg, 100 tablets, Rx Only, Distributed by: Aurobindo Pharma USA, In...
FDA Recall #D-0087-2023 — Class II — December 16, 2022
Product Description
Glycopyrrolate Tablets, USP, 1 mg, 100 tablets, Rx Only, Distributed by: Aurobindo Pharma USA, Inc., East Windsor, NJ 08520, NDC 13107-014-01
Reason for Recall
Failed Impurities/Degradation Specifications
Recalling Firm
Aurolife Pharma, LLC — Dayton, NJ
Classification
Class II — May cause temporary or medically reversible adverse health consequences.
Product Type
Drugs
Product Quantity
7344 bottles
Distribution
Nationwide in the USA and Puerto Rico.
Code Information
Lots: 01422002A1, Expiry: 12/2023; 01421078A3, Expiry: 09/2023
Status
Ongoing
Voluntary / Mandated
Voluntary: Firm initiated
What Should You Do?
Stop using this medication immediately and contact your pharmacist or doctor. Do not flush medications down the drain. Return the product to the place of purchase for a refund or replacement.